This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, M. Articles by Yamamoto, K. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, M. Articles by Yamamoto, K.

(Stroke. 1997;28:1733-1738.)
© 1997 American Heart Association, Inc.

Articles

Increase in Elastin Gene Expression and Protein Synthesis in Arterial Smooth Muscle Cells Derived From Patients with Moyamoya Disease

Mari Yamamoto, PhD; Masaru Aoyagi, MD; Shingo Tajima, MD; Hiroshi Wachi, PhD; Naomi Fukai, MD; Yoshiharu Matsushima, MD; Kiyotaka Yamamoto, PhD

From the Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology (M.Y., M.A., N.F., K.Y.); the Department of Neurosurgery, Tokyo Medical and Dental University (M.A., Y.M.); and the Department of Dermatology, National Defense Medical School, Saitama (S.T., H.W.), Japan.

Correspondence to Kiyotaka Yamamoto, PhD, Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173, Japan. E-mail kyama{at}tmig.or.jp

Background and Purpose Moyamoya disease is a progressive cerebrovascular occlusive disease that is rare in all ages but frequently presents in children. The etiology of the disease is unknown. We examined elastin gene transcripts and elastin synthesis in cultured arterial smooth muscle cells (SMCs) derived from moyamoya patients and compared them with those in SMCs from age-matched control subjects.

Methods We used six cell strains from moyamoya patients and four from controls. The expression of elastin protein was observed by Western blot analysis and metabolic labeling with ³H-valine. Elastin gene transcripts were identified by Northern blot analysis.

Results Elastin mRNA and protein levels were elevated in all SMCs from moyamoya patients compared with control SMCs. Although transforming growth factor-ß1 (TGF-ß1), a potent enhancer of the expression of elastin in arterial SMCs, upregulated elastin mRNA and protein levels in SMCs from both moyamoya patients and control subjects, the maximum levels of elastin synthesis and elastin gene transcripts in response to exogenous TGF-ß1 were significantly greater in moyamoya SMCs than control SMCs. In addition, quiescent moyamoya SMCs secreted significantly more TGF-ß1 into the culture medium than quiescent control SMCs (P<.01).

Conclusions Our findings suggest that moyamoya disease may result, at least in part, from an abnormal regulation of extracellular matrix metabolism that leads to increased steady state levels of elastin mRNA and elastin accumulation in the intimal thickening and that increased elastin accumulation is a stable marker of SMCs from patients with moyamoya disease.

Key Words: extracellular matrix • moyamoya disease • muscle, smooth • transforming growth factor

This article has been cited by other articles:

				C. Grond-Ginsbach, C. Thomas-Feles, I. Werner, R. Weber, F. Wigger, I. Hausser, and T. Brandt Mutations in the Tropoelastin Gene (ELN) Were Not Found in Patients With Spontaneous Cervical Artery Dissections Stroke, August 1, 2000; 31(8): 1935 - 1938. [Abstract] [Full Text] [PDF]

				A. R. Woolfenden, G. W. Albers, G. K. Steinberg, J. S. Hahn, D. C. C. Johnston, and K. Farrell Moyamoya Syndrome in Children With Alagille Syndrome: Additional Evidence of a Vasculopathy Pediatrics, February 1, 1999; 103(2): 505 - 508. [Full Text]